Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /VRNO
chevron_leftBack

Verano Holdings Corp.

VRNO
NEO: VRNO Delayed
0.8800CAD 2.3%
0.6341 USD
As of 24 April 2025, Verano Holdings Corp. has a market cap of $222.91M USD, ranking #16602 globally and #2846 in the United States. It ranks #1649 in the Healthcare sector, and #396 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
16602
Country Rank
2846
Sector Rank
1649
Industry Rank
396
Key Stats
Market Cap
$222.91MUSD
308.7M CAD
Enterprise Value
$672.22MUSD
932.91M CAD
Revenue (TTM)
$912.82MUSD
1.26B CAD
EBITDA (TTM)
$242.64MUSD
336.74M CAD
Net Income (TTM)
-$355.18MUSD
-491.88M CAD
EBITDA Margin
27%
Profit Margin
-39%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
George Archos open_in_new
Employees
3,800
Website
verano.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2.3% 20% -9.2% -47% -82% -86%
Upcoming Earnings
Earnings Date
Thu, May 8

Markets

Exchange Ticker Price
Cboe Canada
MIC: NEOE
PRIMARY
VRNO
Verano Holdings Corp Ordinary Shares - Class A (Sub Voting)
ISIN: CA92338D1015
Shares Out.:
358.95M1 Shares Float: 322.33M2
TV:
SA:
YF:
GF:
BA:
MS:
0.8800 CAD
OTC Markets
MIC: OTCM
VRNOF
Verano Holdings Corp Ordinary Shares - Class A (Sub Voting)
ISIN: CA92338D1015
TV:
SA:
YF:
GF:
BA:
MS:
0.6200 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Verano Holdings Corp.

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Nevada, New Jersey, Ohio, Virginia and West Virginia, and Pennsylvania. It offers cannabis products under the Encore, Avexia, MUV, Savvy, BITS, Verano, and Essence brands for medical and adult-use markets. The company is headquartered in Chicago, Illinois.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
30K%
United Therapeutics Corp.
UTHR
$13.18B
6K%
Neurocrine Biosciences, Inc.
NBIX
$10.21B
4K%
Viatris Inc.
VTRS
$9.32B
4K%
Lantheus Holdings, Inc.
LNTH
$6.94B
3K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Merck KGaA
MRK
$59.42B
52.43B EUR
27K%
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
22K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
21K%
Haleon plc
HLN
$45.57B
34.34B GBP
20K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
10K%